STOCK TITAN

Avalon GloboCare becomes Change Agents Corp. (CHGA) in AI pivot

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Change Agents Corporation, formerly Avalon GloboCare Corp., has amended its Delaware charter to change its corporate name, effective July 20, 2026, and will begin trading on The Nasdaq Capital Market under the new ticker CHGA on July 22, 2026. The CUSIP 05344R302 and shareholder rights remain unchanged, and no shareholder action is required.

The company describes a strategic transformation into a pure-play agentic artificial intelligence software business focused on subscription-based applications. Its portfolio includes the Beacon AI Search Optimization platform, the Catch-Up autonomous content-creation platform, and distribution of the FDA-registered KetoAir breathalyzer device, building on its acquisition of RPM Interactive.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Name change effective date July 20, 2026 Effective date of corporate name change to Change Agents Corporation
Symbol change date July 22, 2026 Date common stock begins trading on The Nasdaq Capital Market under CHGA
CUSIP 05344R302 CUSIP number for the company’s common stock, unchanged after rebranding
Medical device class Class I FDA registration class for the KetoAir ketosis breathalyzer device
agentic artificial intelligence technical
"a developer of agentic artificial intelligence (“AI”) software solutions"
A type of artificial intelligence that can set goals, make decisions, and carry out multi-step actions across digital or physical systems with limited human direction—think of it as an autonomous employee that plans and executes tasks. Investors care because agentic AI can boost productivity and create new revenue streams by automating complex work, but it also introduces risks (unexpected behavior, higher development costs, and regulatory scrutiny) that can affect company value and future cash flows.
Software-as-a-Service (SaaS) technical
"focused on developing agentic AI software-as-a-service (SaaS) applications"
Software-as-a-service (SaaS) is a way of delivering software over the internet where customers pay a subscription to use applications hosted and maintained by a provider, like renting a tool or streaming a service rather than buying and installing it. For investors it matters because subscriptions create predictable, recurring revenue and can scale quickly with low distribution costs, while metrics like customer retention and churn directly affect future cash flow and valuation.
Certificate of Amendment regulatory
"filed a Certificate of Amendment to its Amended and Restated Certificate"
A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.
forward-looking statements regulatory
"Certain statements contained in this press release are “forward-looking statements”"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Class I medical device medical
"registered with the U.S. Food and Drug Administration as a Class I medical device"
A Class I medical device is a regulatory category for low-risk healthcare products that pose minimal potential harm, such as bandages, tongue depressors, or basic hospital furniture. These devices typically face only basic safety and manufacturing oversight rather than lengthy approval processes, so companies can bring them to market faster and with lower development cost. For investors, that means lower regulatory risk and quicker revenue potential, but often thinner margins and intense competition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What major corporate change did Avalon GloboCare (ALBT) announce in this 8-K?

Avalon GloboCare announced a corporate name change to Change Agents Corporation, effective July 20, 2026. The company is also rebranding around an agentic AI software strategy while keeping shareholder rights and the existing CUSIP 05344R302 unchanged, with no shareholder action required.

When will Change Agents Corp. (CHGA) start trading under its new ticker?

The common stock is scheduled to begin trading on The Nasdaq Capital Market under ticker CHGA on July 22, 2026. This follows the July 20, 2026 corporate name change and does not alter existing shareholders’ ownership interests or require any action from them.

What is the new strategic focus of Change Agents Corp. (ALBT/CHGA)?

Change Agents Corp. states it is transforming into a pure-play agentic AI software company focused on Software-as-a-Service applications. It is building intelligent, subscription-based platforms designed to increase revenue, improve digital discoverability, and automate content creation for small businesses, brands, and content creators.

Which AI platforms currently anchor Change Agents Corp. (CHGA)’s portfolio?

The portfolio centers on two SaaS products: Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Both are aimed at large and expanding markets by helping customers boost online visibility and streamline content production workflows.

What non-AI product does Change Agents Corp. (CHGA) still distribute?

The company also distributes the KetoAir breathalyzer device in North America. KetoAir is a non-invasive consumer breathalyzer that measures ketosis levels and is registered with the U.S. Food and Drug Administration as a Class I medical device.

Is any shareholder vote or action required for the Change Agents Corp. rebrand?

No. Under Delaware General Corporation Law Section 242(d)(1), the name change was effected by a Certificate of Amendment without stockholder approval. The company explicitly states that neither the name nor symbol change requires any action by existing stockholders.
false --12-31 0001630212 0001630212 2026-07-17 2026-07-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) July 17, 2026

 

Change Agents Corporation

(Exact name of registrant as specified in its charter)

 

Delaware   001-38728   47-1685128
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I. R. S. Employer
Identification No.)

 

4400 Route 9 South, Suite 3100

Freehold, NJ 07728

(Address of principal executive offices, including ZIP code)

 

(732) 780-4400

(Registrant’s telephone number, including area code)

 

Avalon GloboCare Corp.

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.0001 par value   CHGA   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On July 17, 2026, Avalon GloboCare Corp. (now known as Change Agents Corporation) (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Charter Amendment”), with the Secretary of State of the State of Delaware to change the name of the Company from “Avalon GloboCare Corp.” to “Change Agents Corporation” effective as of July 20, 2026 (the “Name Change”).

 

Pursuant to Delaware General Corporation Law Section 242(d)(1), no stockholder approval was required for the Charter Amendment because it only related to a name change. A copy of the Charter Amendment is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

 

In connection with the Name Change, the Company’s trading symbol for its common stock is expected to commence trading on The Nasdaq Capital Market on July 22, 2026 under the symbol “CHGA” (the “Symbol Change”).

 

Neither the Name Change, nor the Symbol Change, affects the rights of the Company’s stockholders, and no stockholders is required in connection with the Name Change or the Symbol Change. The CUSIP number for the Company’s common stock will remain 05344R302.

 

Item 8.01 Other Events.

 

On July 21, 2026, the Company issued a press release announcing, among other things, the Name Change and Symbol Change. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

The exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K.

 

Exhibit No.   Description of Exhibit
3.1   Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Change Agents Corporation dated July 17, 2026
99.1   Press release dated July 21, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

-1-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 21, 2026 Change Agents Corporation
   
  /s/ Sam Knipper
  Sam Knipper
  Chief Financial Officer

 

-2-

 

Exhibit 99.1

 

 

Avalon GloboCare Announces Strategic Transformation into Agentic AI Software Company; Rebrands as Change Agents Corp.

 

Company to begin trading tomorrow under new Nasdaq ticker symbol CHGA as it advances its portfolio of agentic AI software platforms, including Beacon and Catch-Up

 

Company is actively evaluating additional AI software opportunities in other sectors such as defense and security

 

FREEHOLD, N.J., July 21, 2026 (GLOBE NEWSWIRE) – Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of agentic artificial intelligence (“AI”) software solutions, today announced its strategic transformation into an agentic artificial intelligence software company focused on developing agentic AI software-as-a-service (SaaS) applications. In connection with this transformation, the Company is rebranding as Change Agents Corp., including a corporate name change that reflects its evolution into a pure-play AI software company. The new corporate identity builds upon the Company’s acquisition of RPM Interactive and its continued expansion of its agentic AI software platform.

 

In connection with the rebranding and name change, the Company’s common stock will begin trading effective tomorrow, July 22, 2026, on The Nasdaq Capital Market under the new ticker symbol “CHGA”. The name change, ticker symbol change, and existing CUSIP number do not affect shareholders’ ownership interests, and no action is required by existing shareholders.

 

The new corporate identity reflects the Company’s transformation from a diversified technology business into an agentic AI software company focused on building intelligent, subscription-based platforms that solve critical business problems and allow consumers to automate content creation.

 

To provide investors with additional insight into the Company’s strategic transformation and AI growth initiatives, Michael Mathews, Director, Change Agents Corp., recently participated in an interview, where he discussed Change Agents Corp.’s vision, the Beacon and Catch-Up platforms, and the Company’s long-term growth strategy. Investors can watch the full interview here: https://www.youtube.com/watch?v=bmvI-gtW5kE

 

 

 

 

“Change Agents is more than a new name, it represents our vision for the future,” said Michael Mathews, Director, Change Agents Corp. “We are building agentic AI software products designed to deliver material revenue increases for small businesses, brands, and content creators. As artificial intelligence transforms how businesses market, engage customers, and compete online, we believe our platforms are well positioned to help customers capitalize on this shift while creating sustainable, recurring revenue and long-term value for our shareholders.”

 

The Company’s current AI software portfolio is centered around two complementary Software-as-a-Service (SaaS) platforms designed to address large and rapidly expanding market opportunities:

 

Beacon, expected to launch in late Q3 2026, is an AI Generative Engine Optimization platform that helps businesses optimize their digital presence for AI-powered search engines. As consumers increasingly rely on AI assistants for recommendations rather than using traditional search engines, Beacon is designed to improve AI discoverability, monitor brand visibility across AI platforms, and help businesses capture new customer opportunities in the emerging AI search economy.

 

Catch-Up, currently in Phase 2 development, is being transformed into a fully autonomous, agentic AI-powered content creation platform. The product is designed for podcasters and social media influencers with very little technical expertise to autonomously generate personalized video content across multiple social media platforms. The platform is being developed in collaboration with Caylent, an Amazon Web Services (AWS) Premier Tier Services Partner.

 

In addition, the Company is actively evaluating additional AI software solutions to expand its technology portfolio, with a particular focus on high-growth sectors including defense, military, security, and other enterprise applications. By leveraging its expertise in AI, the Company aims to deliver innovative solutions that can address mission-critical challenges while creating new long-term commercial opportunities.

 

About Change Agents Corp.

 

Change Agents Corp. (Nasdaq: CHGA) is an artificial intelligence software company focused on developing agentic AI applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The Company’s current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, Change Agents is focused on delivering innovative AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns.

 

2

 

 

Change Agents is also distributing the KetoAir™ breathalyzer device a non-invasive consumer breathalyzer that measures ketosis levels and is sold in North America, which is registered with the U.S. Food and Drug Administration as a Class I medical device.

 

For more information about Change Agents Corp, please visit www.changeagentscorp.com.

 

Forward-Looking Statements


Certain statements contained in this press release are “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve several risks and uncertainties. You can identify these statements by the fact that they use words such as “will”, “anticipate”, “estimate”, “expect”, “should”, “may”, and other words and terms of similar meaning or use of future dates; however, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, including statements regarding the Company’s commercialization, distribution and sales of its products and the product’s ability to compete with other similar products. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the SEC, accessible through the SEC’s website (http://www.sec.gov), including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K filed or furnished with the SEC. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors, including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. The Company disclaims any obligation to update forward-looking statements. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release. The contents of any website referenced in this press release are not incorporated by reference herein.

 

Contact Information:

Change Agents Corp.

ir@changeagentscorp.com

 

Investor Relations:

Crescendo Communications, LLC

Tel: (212) 671-1020 Ext. 304

CHGA@crescendo-ir.com

 

3

 

Filing Exhibits & Attachments

5 documents